サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1547765

皮吸収型皮膚パッチの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Transdermal Skin Patches Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 181 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
皮吸収型皮膚パッチの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経皮吸収型皮膚パッチ市場の世界需要は、2023年の84億1,000万米ドルから2032年には約133億米ドルの市場規模に達すると推定され、調査期間2024～2032年のCAGRは5.23%です。

経皮吸収型皮膚パッチは経皮技術の一種です。経皮吸収パッチは、経皮吸収技術の一種であり、皮膚に貼る薬用粘着パッチで、特定量の薬剤を送達します。これらのパッチは、拡散技術を用いて皮膚から薬剤を投与し、その後長期間にわたって血流中に放出されます。これらのパッチは、ホルモンと心臓疾患の治療に効果的に使用されます。これらのパッチは、片頭痛、パーキンソン病、アルツハイマー病、脳卒中、HIV、骨粗しょう症、皮膚科関連の問題、レストレスレッグ症候群の治療にも使用されています。

市場力学

市場成長の主要要因は、吐き気や嘔吐を伴う従来の薬剤療法（胃腸毒性薬剤療法）よりも経皮吸収型薬剤療法の利点が増加していることです。経皮吸収型製剤は非侵襲的であるため、静脈内投与や非経口投与による不便さを軽減することができます。主要利点は、パッチが患者への薬剤の制御放出を提供することで、一般的には、薬剤の貯蔵を覆う多孔質膜か、体温によって接着剤に沈着した薬剤の薄層が溶ける。さらに、医薬品開発のための資金調達や投資が増加していることも、市場の成長を後押ししています。しかし、皮膚は様々な活性物質を吸収することができないため、市場の成長を阻害すると予想されます。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは経皮吸収型皮膚パッチの世界市場における各セグメントを包括的に評価することもできます。経皮吸収型皮膚パッチ産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

経皮吸収型皮膚パッチ市場レポートのこのセクションでは、国別と地域別のセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスの対象層を特定する上で、今後の機会を支援します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける経皮吸収型皮膚パッチ市場の現在と将来の需要について、地域別の展望を取り上げます。さらに、本レポートは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 経皮吸収型皮膚パッチ-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 経皮吸収型皮膚パッチの世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 実績データと予測データ
  • 製品タイプ別分析
  • リザーバー
  • ドラッグインアドヒーシブ（単層、多層）
  • マイクロニードル
  • マトリックス
  • その他（蒸気など）

第6章 経皮吸収型皮膚パッチの世界市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • 疼痛管理
  • ホルモン障害
  • 禁煙補助薬
  • 神経疾患
  • 心血管疾患
  • その他（乗り物酔い、過活動膀胱など）

第7章 経皮吸収型皮膚パッチの世界市場分析：販売タイプ別

  • 販売タイプ別概要
  • 実績データと予測データ
  • 販売タイプ別分析
  • 処方薬
  • 市販薬（OTC）

第8章 経皮吸収型皮膚パッチの世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 経皮吸収型皮膚パッチの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 経皮吸収型皮膚パッチ企業の競合情勢

  • 経皮吸収型皮膚パッチ市場の競合
  • パートナーシップ/提携/協定
  • 合併・買収
  • 新製品発売
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Hisamitsu Pharmaceutical Co. Inc.
  • Viatris Inc.
  • Nitto Denko Corporation
  • Novartis AG
  • Luye Pharma Group
  • Teikoku Pharma
  • Samyang Holdings Corporation
  • Gedeon Richter PLC
  • AdhexPharma
  • Sparsha Pharma International Pvt Ltd
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Reservoir Market Sales By Geography (USD MN)
  • Drug-in-Adhesive (Single Layer, Multilayer) Market Sales By Geography (USD MN)
  • Microneedle Market Sales By Geography (USD MN)
  • Matrix Market Sales By Geography (USD MN)
  • Others (Vapor, etc.) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Hormonal Disorders Market Sales By Geography (USD MN)
  • Smoking Reduction and Cessation Aid Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Others (Motion Sickness, Overactive Bladder, etc.) Market Sales By Geography (USD MN)
  • Analysis By Sales Type (USD MN)
  • Prescription Market Sales By Geography (USD MN)
  • Over-the-Counter (OTC) Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Transdermal Skin Patches Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Transdermal Skin Patches Report
  • Market Research Process
  • Market Research Methodology
  • Global Transdermal Skin Patches Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Sales Type
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Reservoir Market Sales By Geography (USD MN)
  • Drug-in-Adhesive (Single Layer, Multilayer) Market Sales By Geography (USD MN)
  • Microneedle Market Sales By Geography (USD MN)
  • Matrix Market Sales By Geography (USD MN)
  • Others (Vapor, etc.) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Hormonal Disorders Market Sales By Geography (USD MN)
  • Smoking Reduction and Cessation Aid Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Others (Motion Sickness, Overactive Bladder, etc.) Market Sales By Geography (USD MN)
  • Global Market Analysis By Sales Type (USD MN)
  • Prescription Market Sales By Geography (USD MN)
  • Over-the-Counter (OTC) Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11213473

The global demand for Transdermal Skin Patches Market is presumed to reach the market size of nearly USD 13.3 Billion by 2032 from USD 8.41 Billion in 2023 with a CAGR of 5.23% under the study period 2024-2032.

A transdermal patch is a type of transdermal technology. It is a medicated adhesive patch placed on the skin to deliver a specific dose of medication. These patches provide medication dose though the skin using the diffusion technique, which later gets released in the bloodstream over a long period. These patches are effectively used for the treatment of hormonal and cardiac disorders. These patches are also used to treat migraine, Parkinsons disease, Alzheimer's, strokes, HIV, osteoporosis, dermatology-related issues, and restless leg syndrome treatments.

MARKET DYNAMICS

The primary factor contributing to the growth of the market is the increasing advantages of transdermal medicine over the conventional way of medications (medications for gastrointestinal toxicity), resulting in nausea and vomiting. As they are non-invasive in nature, they reduce the inconvenience caused due to intravenous or parenteral therapies. The main advantage is that the patch provides a controlled release of the medication into the patient, generally through either a porous membrane covering the storage of medication or through body heat melting thin layers of medication deposited in the adhesive. Additionally, increasing funding and investments for drug development boosts the market growth. However, the skin's inability to absorb a range of active substances is expected to impede the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Transdermal Skin Patches. The growth and trends of Transdermal Skin Patches industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Transdermal Skin Patches market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Reservoir
  • Drug-in-Adhesive (Single Layer, Multilayer)
  • Microneedle
  • Matrix
  • Others (Vapor, etc.)

By Application

  • Pain Management
  • Hormonal Disorders
  • Smoking Reduction and Cessation Aid
  • Neurological Disorders
  • Cardiovascular Disorders
  • Others (Motion Sickness, Overactive Bladder, etc.)

By Sales Type

  • Prescription
  • Over-the-Counter (OTC)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Transdermal Skin Patches market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transdermal Skin Patches market include Hisamitsu Pharmaceutical Co. Inc., Viatris Inc., Nitto Denko Corporation, Novartis AG, Luye Pharma Group, Teikoku Pharma, Samyang Holdings Corporation, Gedeon Richter PLC, AdhexPharma, Sparsha Pharma International Pvt Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. TRANSDERMAL SKIN PATCHES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Sales Type
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product Type
  • 5.4. Reservoir Historic and Forecast Sales By Regions
  • 5.5. Drug-in-Adhesive (Single Layer, Multilayer) Historic and Forecast Sales By Regions
  • 5.6. Microneedle Historic and Forecast Sales By Regions
  • 5.7. Matrix Historic and Forecast Sales By Regions
  • 5.8. Others (Vapor, etc.) Historic and Forecast Sales By Regions

6. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Application
  • 6.4. Pain Management Historic and Forecast Sales By Regions
  • 6.5. Hormonal Disorders Historic and Forecast Sales By Regions
  • 6.6. Smoking Reduction and Cessation Aid Historic and Forecast Sales By Regions
  • 6.7. Neurological Disorders Historic and Forecast Sales By Regions
  • 6.8. Cardiovascular Disorders Historic and Forecast Sales By Regions
  • 6.9. Others (Motion Sickness, Overactive Bladder, etc.) Historic and Forecast Sales By Regions

7. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY SALES TYPE

  • 7.1. Overview By Sales Type
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Sales Type
  • 7.4. Prescription Historic and Forecast Sales By Regions
  • 7.5. Over-the-Counter (OTC) Historic and Forecast Sales By Regions

8. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Distribution Channel
  • 8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Retail Pharmacies Historic and Forecast Sales By Regions
  • 8.6. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE TRANSDERMAL SKIN PATCHES COMPANIES

  • 10.1. Transdermal Skin Patches Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF TRANSDERMAL SKIN PATCHES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Hisamitsu Pharmaceutical Co. Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Viatris Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Nitto Denko Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Novartis AG
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Luye Pharma Group
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Teikoku Pharma
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Samyang Holdings Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Gedeon Richter PLC
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. AdhexPharma
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Sparsha Pharma International Pvt Ltd
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies